Enabling the control of reperfusion parameters in out-of-hospital cardiac arrest: First applications of the CARL system.

extracorporeal cardiopulmonary resuscitation ischemia-reperfusion injury out-of-hospital cardiac arrest targeted reperfusion

Journal

Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166

Informations de publication

Date de publication:
03 2023
Historique:
pubmed: 24 11 2022
medline: 17 2 2023
entrez: 23 11 2022
Statut: ppublish

Résumé

There is increasing evidence for extracorporeal cardiopulmonary resuscitation (ECPR) as a rescue therapy for selected patients in refractory cardiac arrest (CA). Besides patient selection, the control of reperfusion parameters is of eminent importance. Especially in out-of-hospital CA, monitoring and individualized, targeted reperfusion remains a great challenge for emergency personnel. The CARL® system is designed to enable an early control of a variety of reperfusion parameters and to pursue a targeted reperfusion strategy in ECPR. We report the first 10 ECPR applications of the CARL® system in Regensburg, Germany. Early blood gas analysis, oxygen titration and pressure monitoring were feasible and enabled an individualized and targeted reperfusion strategy in all patients. After suffering from refractory CA and prolonged resuscitation attempts, five out of the first 10 patients survived and were successfully discharged from the hospital (CPC one on hospital discharge). Application of the CARL® system contributed to early monitoring and control of reperfusion parameters. Whether targeted ECPR may have the potential to improve outcomes in refractory OHCA remains the subject of future investigations.

Identifiants

pubmed: 36416680
doi: 10.1177/02676591221141325
pmc: PMC9932608
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

436-439

Références

Intensive Care Med. 2020 May;46(5):973-982
pubmed: 32052069
JTCVS Open. 2021 Oct 20;8:47-52
pubmed: 36004144
Scand J Trauma Resusc Emerg Med. 2021 Oct 9;29(1):147
pubmed: 34627354
Lancet. 2020 Dec 5;396(10265):1807-1816
pubmed: 33197396
Clin Res Cardiol. 2019 May;108(5):455-464
pubmed: 30361819
J Thorac Dis. 2019 Jun;11(Suppl 10):S1464-S1470
pubmed: 31293795
Resuscitation. 2021 Apr;161:115-151
pubmed: 33773825
Resuscitation. 2015 Aug;93:53-7
pubmed: 26051810
Circulation. 2016 Dec 20;134(25):2084-2094
pubmed: 27760796
Resusc Plus. 2020 Nov 21;4:100044
pubmed: 34223319
Nat Rev Neurosci. 2021 Sep;22(9):553-572
pubmed: 34290397
Scand J Trauma Resusc Emerg Med. 2017 Jul 10;25(1):66
pubmed: 28693585
Resuscitation. 2020 Mar 1;148:218-226
pubmed: 32027980

Auteurs

Alois Philipp (A)

Department of Cardiothoracic Surgery, 9202University Medical Center Regensburg, Regensburg, Germany.

Jan-Steffen Pooth (JS)

Department of Cardiovascular Surgery, 39070University Medical Center Freiburg, Freiburg, Germany.
Faculty of Medicine, 199900Albert-Ludwigs-University, Freiburg, Germany.
Resuscitec GmbH, Freiburg, Germany.

Christoph Benk (C)

Department of Cardiovascular Surgery, 39070University Medical Center Freiburg, Freiburg, Germany.
Faculty of Medicine, 199900Albert-Ludwigs-University, Freiburg, Germany.
Resuscitec GmbH, Freiburg, Germany.

Thomas Mueller (T)

Department of Internal Medicine II, University Medical Center Regensburg, Regensburg, Germany.

Dirk Lunz (D)

Department of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH